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238The use of dextran and carbon dioxide for optical
coherence tomography in the superﬁcial femoral
artery
Matthew T. Allemang, MD,a Ryan O. Lakin, MD,b Tomoaki Kanaya, MD,c Benjamin A. Eslahpazir, BS,d
Hiram G. Bezerra, MD,e and Vikram S. Kashyap, MD,b Cleveland, Ohio
The following case report describes using carbon dioxide (CO2) as contrast media for intravascular optical coherence
tomography (OCT) imaging in the superﬁcial femoral artery. For initial OCT imaging, 20 mL of iodinated contrast was
used during automated pullback. This was followed by 20 mL of hand-injected dextran 40 in normal saline, and ﬁnally
hand-injected 50 mL of CO2. CO2 gave comparable erythrocyte clearance and imaging quality compared with dextran
and iodinated contrast. To our knowledge, this is the ﬁrst reported case using both dextran and CO2 with OCT imaging
of the superﬁcial femoral artery. Using CO2 is a viable option in patients with contraindications to contrast or dextran
use. (J Vasc Surg 2014;59:238-40.)Endovascular interventions for peripheral artery disease
are common across the United States and globally.1 Intra-
vascular optical coherence tomography (OCT) is an
emerging imaging modality based on near-infrared light
projected via a catheter-based system similar to intravas-
cular ultrasound.2 This technology produces images with
an extremely ﬁne resolution of 10 to 15 mm and has
been used more often in the coronary literature, with
limited use in the setting of infrainguinal peripheral artery
disease.3,4 In addition to ﬁner resolution, current OCT
technology offers a 2-second acquisition time for 54-mm
length segments. This is much faster than intravascular
ultrasound, and OCT is currently being developed for
longer lengths. The hope is for it to be used both before
and after endovascular interventions to optimize treatment
choices and ensure stent wall apposition, but to date, it has
only been used on a limited basis.
The high resolution capabilities of OCT may help
before and after an intervention to predict outcomes or
identify errors in stent deployment. But there is one speciﬁc
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jected during image acquisition such as contrast, dextran,
and saline.5,6 In peripheral interventions, alternative con-
trast agents can be used that are contraindicated in the
coronary circulation. This allows a unique opportunity for
optimizing OCT in the ﬁeld of peripheral interventions
that cannot be performed in coronary imaging.
Currently, carbon dioxide (CO2) is used as medium for
digital subtraction angiography in patients with chronic
renal insufﬁciency. Our objective was to evaluate OCT in
the peripheral arteries with different contrast media. The
following case report is a proof of concept using CO2 in
the distal superﬁcial femoral artery (SFA). The protocol
was approved by the University Hospitals Institutional
Review Board.
CASE REPORT
A 77-year-old Caucasian female with a past medical history of
coronary artery disease, hypertension, and aortic and mitral valve
replacement presented to our outpatient clinic with a punctate
nonhealing ulcer behind the left medial malleolus. Her outside
hospital angiogram showed distal SFA/proximal popliteal artery
severe stenosis with reconstitution and three vessel outﬂow. She
subsequently underwent angiography with concomitant OCT
and endovascular intervention. After local anesthesia, a short 5-F
sheath was inserted in an antegrade fashion under ultrasound guid-
ance in the left common femoral artery. A 0.035-mm  145-cm
angled Glidewire (Terumo, Sumerset, NJ) was used to navigate
through the distal SFA lumen until the occlusion was encountered.
This was followed by a Trailblazer catheter (Covidien, Plymouth,
Minn) and exchanged for a Glidewire for a 0.014” HI-Torque
Spartacore Peripheral Guide Wire (Abbott Laboratories, Abbott
Park, Ill). The OCT catheter (Dragonﬂy; St Jude Medical, Little
Canada, Minn) was placed over this wire just past an area of
stenosis. Of note, the tip of the 5-F sheath was approximately 10
cm from the most distally imaged area of the OCT catheter. At
this point, 20 mL of Omnipaque 350 iodinated contrast (GE
Healthcare, Waukesha, Wisc) was hand-injected through the
Fig. Selective angiography of left superﬁcial femoral artery (SFA) with corresponding optical coherence tomography
(OCT) imaging using contrast, dextran, and carbon dioxide (CO2) at the same magniﬁcation but using the same index
of refraction. Magniﬁcation, 1.3.
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This was followed by 20 mL of hand-injected dextran 40 in normal
saline (Hospira, Lake Forest, Ill), and, ﬁnally, hand-injected 50 mL
of CO2.
Images shown in the Fig are optimum sections from each
medium pullback. Each image is shown at the same zoom but
captured while referencing the same index of refraction. This
method gave a falsely appearing smaller CO2 image when
compared with the others. After the imaging protocol was
completed, the patient underwent successful endovascular recana-
lization of the occluded SFA and popliteal vessels with angioplasty
balloon inﬂations.
DISCUSSION
To our knowledge, this is the ﬁrst reported case using
dextran and CO2 with OCT imaging of the SFA. Most
notably, we had the opportunity to compare qualitative
ﬁndings of plaque interpretation as well as lumen dimen-
sions against 100% iodine contrast and dextran 40. Critical
technical notes include the importance of media catheter
injection to be located as close to the area of interest as
possible. Although the CO2 images presented here show
a large amount of surface area, this was not consistent
throughout the entire pullback. The CO2 dissipates quickly
through the artery; a 50-mL bolus may be insufﬁcient foroptimal image capture and may have been alleviated if an
automated CO2 injection system was used instead. We
also observed phenomena of blood/gas tension artifact
between the OCT catheter and the artery wall in some of
the images shown, where blood does not clear completely
and the luminal surface is obscured. Anecdotally, dextran
40 gave a comparable image for the length of artery of
interest when compared with iodinated contrast. Finally,
all images were captured using the same index of refraction
for contrast (1.449), and although the CO2 images may
appear smaller, if corrected for the proper index of refrac-
tion (dextran: 1.369 and CO2 1.000), similar lumen
dimensions were achieved between the three mediums.
This case represents the initiation of a pilot study in-
corporating the three mediums in patients undergoing
lower extremity arterial angiogram as part of the
OPTical Imaging Measurement of Intravascular Solution
Efﬁcacy (OPTIMISE) Trial (ClinicalTrials.gov Identiﬁer
NCT0173872).
We are currently in the infant stages of using OCT in
our practice. The role that OCT may play in peripheral
interventions remains unknown. We hope to detail this
more in the OPTIMISE study comparing all three modal-
ities in more patients. It would be difﬁcult to complete an
endovascular intervention exclusively without angiography,
JOURNAL OF VASCULAR SURGERY
240 Allemang et al January 2014but if the patient has a contrast allergy or chronic kidney
disease, our hope is that CO2 could be used solely to obtain
the angiogram and OCT imaging before and after the
intervention.
CONCLUSIONS
OCT is an emerging technology with tremendous
potential for clinical application in peripheral vascular
disease. Using CO2 as a blood clearance medium during
acquisition of OCT images in the SFA may be a viable
option to avoid nephrotoxicity in patients with chronic
renal insufﬁciency or ﬂuid overload in those with conges-
tive heart failure.REFERENCES
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